- Home
- FRSX vs COEP Comparison
FRSX vs COEP Comparison
Compare FRSX & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- COEP
- Stock Information
- Founded
- FRSX N/A
- COEP 2017
- Country
- FRSX Israel
- COEP United States
- Employees
- FRSX N/A
- COEP N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRSX Technology
- COEP Health Care
- Exchange
- FRSX Nasdaq
- COEP Nasdaq
- Market Cap
- FRSX 31.1M
- COEP 32.4M
- IPO Year
- FRSX 2017
- COEP N/A
- Fundamental
- Price
- FRSX $0.89
- COEP $10.52
- Analyst Decision
- FRSX
- COEP
- Analyst Count
- FRSX 0
- COEP 0
- Target Price
- FRSX N/A
- COEP N/A
- AVG Volume (30 Days)
- FRSX 110.3K
- COEP 109.2K
- Earning Date
- FRSX 03-26-2025
- COEP 03-25-2025
- Dividend Yield
- FRSX N/A
- COEP N/A
- EPS Growth
- FRSX N/A
- COEP N/A
- EPS
- FRSX N/A
- COEP N/A
- Revenue
- FRSX $473,000.00
- COEP N/A
- Revenue This Year
- FRSX N/A
- COEP N/A
- Revenue Next Year
- FRSX N/A
- COEP N/A
- P/E Ratio
- FRSX N/A
- COEP N/A
- Revenue Growth
- FRSX 3.28
- COEP N/A
- 52 Week Low
- FRSX $0.57
- COEP $2.31
- 52 Week High
- FRSX $2.63
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- FRSX 38.61
- COEP 48.65
- Support Level
- FRSX $0.92
- COEP $9.27
- Resistance Level
- FRSX $1.05
- COEP $12.95
- Average True Range (ATR)
- FRSX 0.09
- COEP 1.59
- MACD
- FRSX -0.01
- COEP -0.33
- Stochastic Oscillator
- FRSX 3.74
- COEP 38.56
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its advanced systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.